Corcept Therapeutics (CORT) Tax Rate (2017 - 2026)

Corcept Therapeutics has disclosed Tax Rate across 10 years of filings, most recently posting 28.97% for Q1 2026.

• Tax Rate for Q1 2026 came in at 28.97%, up 14230.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 290.31% (down 29186.0% YoY), and the FY2025 annual result was 49.94%, down 6250.0% from the prior year.
• Tax Rate came in at 28.97% for Q1 2026 at Corcept Therapeutics, up from 145.09% in the prior quarter.
• In the past five years, Tax Rate ranged from a high of 31.61% in Q4 2022 to a low of 145.09% in Q4 2025.
• The 5-year median for Tax Rate is 14.1% (2023), against an average of 6.11%.
• Across the five-year window, Tax Rate sank 14888 bps in 2025 and surged 14230 bps in 2026, its largest moves.
• Corcept Therapeutics' Tax Rate stood at 31.61% in 2022, then tumbled by 53 bps to 14.72% in 2023, then sank by 74 bps to 3.8% in 2024, then plunged by 3920 bps to 145.09% in 2025, then jumped by 120 bps to 28.97% in 2026.
• The last three Tax Rate figures came in at 28.97% (Q1 2026), 145.09% (Q4 2025), and 29.03% (Q3 2025), per Business Quant data.